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ABSTRACT 
 
Background: Columnar cell lesions of breast are increasingly being encountered in breast biopsies because of their 
associated micro calcifications which are detected on mammographic screening.Observational studies suggest the 
co-existence of Columnar cell lesions with more advanced lesions of breast like Ductal carcinoma in situ,Atypical 
ductal hyperplasia and Invasive carcinoma. The presence of Columnar cell lesionneeds careful search for other 
atypical breast lesionsin proximity. Aim: To study the occurrence of Columnar cell lesions in Neoplastic and Non-
Neoplastic breast lesions and evaluate the type of lesion with respect to category of breast lesion.Materials and 
methods: This is an observational study conducted in the Department of Pathology,Gandhi hospitalfrom January 
2016 to December 2017.H&E stained sections of Neoplastic and Non-Neoplastic breast lesions were reviewed and 
associated Columnar cell changes were evaluated.Results:Total200 breast lesions were studiedout of which 134 
showed Columnar cell lesions. 90% cases of fibrocystic disease and 60% of fibroadenoma cases were associated 
with CCL and the predominant type of lesionis Columnar cell change. 80% cases of Ductal carcinoma insituand 
40% of Infiltrative duct cell carcinoma cases showed CCL and the common lesion is Columnar cell hyperplasia 
without atypia.Conclusion: Columnar cell lesions were observed in both Neoplastic and Non-Neoplastic breast 
lesions. Based on previous observational studies cancer risk associated with CCL is only mild on long term follow 
up. However detection of CCL in biopsy should prompt additional scrutiny for other pathological changes. 
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duct lobular unit 
 
Introduction 
Columnar cell lesions (CCL) are first described in 1945 
by Foote and Stewart named as Blunt duct adenosis[1], 
later mentioned in 1979 by Azzopardi as Clinging 
carcinoma[2]. Also CCL has been included in the 
recent WHO classification of breast (2016) under the 
category of Intraductal proliferative lesions.CCL is 
characterized by enlarged TDLUs with dilated acini 
lined by epithelial cells showing columnar cell 
morphology (Fig 1&2).  
_____________________________ 
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Luminal secretions and associated calcification are 
common [3]. In some cases there is accompanying 
atypia.Columnar cells are epithelial cells which have 
an elongated shape with a height about 4 times the 
width. The cells contain uniform ovoid to elongated 
nuclei with inconspicuous or absent nucleoli. Apical 
snouts, intraluminal secretions and microcalcifications 
are seen.  
The scheme described by Schnitt and Vincent-Salomon 
was used for classifying CCLs into four categories 
[4].They are named according to the number of layers 
of columnar cells present, and whether or not these 
cells have any atypical features. Columnar cell change 
(CCC) is Dilated TDLU, lined by one or two layers of 
columnar type epithelium. In Columnar cell 
hyperplasia (CCH)TDLUs are lined by more than two 
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stratified cell layers. In Columnar cell change with 
atypia and columnar cell hyperplasia with atypia,   
cytonuclear atypia is superimposed showing relatively 
round or ovoid nuclei that are not regularly oriented 
along the basement membrane. The nuclei are 
irregular, often with prominent nucleoli and show an 
increase in the nuclear/cytoplasmic ratio. Mitotic 
figures may bepresent. According to the 2003 WHO 
classification, CCL with atypia were mentioned as flat 
epithelial atypia (FEA) [5].Complex architectural 
patterns as seen in ADH and low grade DCIS are 
lacking.Intraluminal secretions and associated 
calcifications are responsible for their mammographic 
detection[3]. Breast columnar cell lesions will show 
microcalcifications, and they usually have a round or 
pleomorphic appearance, and a small number show 
branching microcalcifications.  
Due to presence of CCL in proximity to invasive and 
non- invasive breast carcinoma observational studies 
suggest the co-existence of CCLwith more advanced 
lesions of breast like DCIS and invasive carcinoma [6, 
7]. This is supported largely by the immunological and 
molecular evidence linking CCL to atypical 
hyperplasia, DCIS and IDCC[8].The presence of 
Columnar cell lesion needs careful search for other 
atypical breast lesions in proximity to gain more 
insight into its clinical significance. 
Materials and methods 
Present study is an observational study conducted in 
the Department of Pathology, Gandhi hospital for a 
period of 2 years from January 2016 to December 
2017. Haematoxylin &Eosin stained sections of 
Neoplastic and Non-Neoplastic breast lesions were 
reviewed for the presence or absence of Columnar cell 
lesion .When CCL is present, the type of CCL with 
corresponding percentage was tabulated. The scheme 
described bySchnitt and Vincent-Salomon was used for 
classifying CCLs into following four categories. 
Columnar Cell Change with atypia,columnar cell 
change without atypia, Columnar cell hyperplasia with 
atypia and Columnar cell hyperplasia without atypia. 
Results 
Total 200 cases with breast lesions were studied out of 
which 134 cases showed Columnar cell lesions.CCC 
was noted in 82 cases and CCH without atypia in 52 
cases. 60 cases were of Fibrocystic disease (Non-
Neoplastic category) and80 were Fibroadenoma(benign 
category).20 cases of DCIS and 40 IDCC(malignant 
category) were evaluated for Columnar cell lesions.  
90% cases of Fibrocystic disease, 60% of Fibro 
adenomas,80% cases of DCIS and 40% IDCC cases 
showed CCL. (Table1) 
 
Table 1: 20 cases of DCIS and 40 IDCC(malignant category) were evaluated for Columnar cell lesions.  90% 
cases of Fibrocystic disease, 60% of Fibro adenomas,80% cases of DCIS and 40% IDCC cases showed CCL 
Type of breast lesion Total no of cases No of cases with CCL Percentage 
Fibrocystic disease 60 54 90% 
Fibroadenoma 80 48 60% 
DCIS 20 16 80% 
IDCC 40 16 40% 
 
60 cases of Fibrocystic disease(FCD) were evaluated out of which 54 cases showed CCL. The predominant CCL is 
columnar cell changewhich is seen in 89% of cases.The remaining 11% of cases showed columnar cell hyperplasia 
without atypia.(Table 2)(Fig 3) 
Table 2 :  Fibrocystic disease 
Type of CCL No of cases Percentage 
CCC 48        89% 
CCH without atypia 06        11% 
CCL-A         ---         --- 
Total 54       100% 
 
Out of 48 cases of Fibroadenoma with CCL 32 (66.7%) showed CCC whereas 16 (33.3%) cases showed CCH 
without atypia. (Table 3)(Fig 4) 
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Table 3: Fibroadenoma 
Type of CCL No of cases Percentage 
CCC 32        66.7% 
CCH without atypia 16        33.3% 
CCL-A         ---         --- 
Total 48       100% 
 
In contrast to the type of Columnar cell lesions found in majority cases of Fibrocystic disease and Fibroadenoma  the 
predominant CCL found  in Ductal carcinoma insitu is Columnar cell hyperplasia(CCH) without atypia.87.5% cases 
of DCIS with CCL  showed CCH without atypia. Only 12.5% cases showed Columnar cell change.(Table 4)(Fig 5) 
 
Table 4 : Ductal carcinoma in situ 
Type of CCL No of cases Percentage 
CCC 02 12.5% 
CCH without atypia 14 87.5% 
CCL-A         ---         --- 
Total 16       100% 
 
 40% cases of Infiltrating duct cell carcinoma were associated with Columnar cell lesion. The type of CCL in all the 
cases is CCH without atypia.(Table 5)(Fig 6) 
Table 5:   infiltrating duct cell carcinoma 
Type of CCL No of cases Percentage 
CCC  --- --- 
CCH without atypia 16 100% 
CCL-A         ---         --- 
Total 16       100% 
 
Discussion 
Columnar cell lesions have recently become a highly 
controversial area in breast pathology.Over the past 
few years there has been an abundance of evidence 
linking them to atypical hyperplasia and invasive 
carcinomas.We conducted this observational study to 
gain more insight into the co-occurrence of CCL with 
other breast lesions. We found an incidence of CCL to 
be 67% in the current study, compared to study done 
by Seema etal[9] which showed an incidence of 37%. 
In a study of 100 breast biopsies performed for 
microcalcifications, Fraser et al[3] found CAPPS 
in42% cases. The term CAPPS was formerly used for 
lesions that are now classified as CCLs. 
Our results in the study point to highest incidence 
(90%) of co-occurrence of CCL with FCD. The 
predominant CCL is Columnar cell change which is 
seen in 89% of cases. The remaining 11% of cases 
showed Columnar cell hyperplasia without atypia. 
Similar findings were seen in the study done by Seema 
et al [9]where the commonest associated lesion was 
Fibrocystic change which is seen in 54% of cases. In a 
study done byIm Choi Soo et al [10]among 1,038 FCD 
cases, CCLs were found in 18.9%, Columnar cell 
change (CCC) in 12.5%, Columnar cell hyperplasia 
(CCH) in 5.3%  and Flat epithelial atypia (FEA) in 
1.1%.In the present study also the commonest type of 
CCL is CCC which is in concordance with the study 
done by Im Choi Soo et al. 
80% of DCIS cases showed CCL with majority of them 
showing CCH without atypia.Fraser et al [3] found that 
low-grade DCIS coexisted with CCLs in 56% of cases, 
whereas high-grade DCIS was associated with CCLs in 
only 19% of cases.The co-existence of CCL with 
invasive carcinoma was 40% with all cases showing 
CCH.A study done by Lakshmi Priya et 
al[11]Columnar cell lesions and other proliferative 
breast lesions were seen in 56.7% mastectomies. DCIS 
was the commonest lsion seen in 40% cases. FEA, 
CCC, CCH were seen in 26.7%, 20% and 5% of cases 
respectively. In a study done by Demiraley et al [12] 21 
mastectomy specimens containing CCLs coexisting 
with IDCC were analyzed and found CCL with atypia 
in 33% and without atypia in 67% cases.In the present 
study all the cases of IDCC with CCL are associated 
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with CCH without atypia. Present study did indicate 
that risk may be increased for those having CCL with 
hyperplasia, although this could have been a chance 
finding due to the small number of cases studied.CCLs 
without atypia a wait and see approach are usually 
followed and these CCLs are therefore regarded as 
clinically insignificant. It has also been recommended 
that the identification of CCL with cytological atypia 
on core biopsies should lead to an open excision, 
because of increased risk of advanced lesions in 
proximity. 
 
 
 
Conclusion 
 
Based on previous studies the cancer risk associated 
with CCL is only mild on long term follow up.This 
assertion will still need substantiation by more studies 
with large numbers and long term follow up. It is of 
paramount importance that the spectrum of CCL 
should be recognised by practising surgical 
pathologists who interpret breast specimens, 
specifically in identifying CCL with cytological atypia, 
so that proper management can be instituted. Whenever 
CCL is diagnosed, careful search for other atypical 
breast lesions like DCIS,ADH and Invasive carcinoma 
should be made. 
 
 
 
Fig 1:TDLU   Fig 2: CCL 
 
Fig 3:  FCD with CCL      Fig 4: Fibroadenoma with CCL 
 
             
     
 
 
 
Fig 5:  DCIS with CCL  Fig 6: IDCC with CCL 
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